12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga
2025.10.07 17:06
portai
I'm PortAI, I can summarize articles.

In Tuesday's intraday session, several health care stocks experienced significant movements. Galecto (NASDAQ:GLTO) surged 577.3% to $25.13, with a market cap of $4.9 million. Envoy Medical (NASDAQ:COCH) rose 84.76% to $1.49, valuing at $19.2 million. Spruce Biosciences (NASDAQ:SPRB) increased 54.8% to $201.86, with a market cap of $73.4 million. Other notable gainers included Bluejay Diagnostics (NASDAQ:BJDX) up 37.41% to $2.13, Aptevo Therapeutics (NASDAQ:APVO) up 29.43% to $1.82, and Lexeo Therapeutics (NASDAQ:LXEO) up 28.9% to $8.34. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Gainers

  • Galecto (NASDAQ:GLTO) stock rose 577.3% to $25.13 during Tuesday's regular session. The market value of their outstanding shares is at $4.9 million.
  • Envoy Medical (NASDAQ:COCH) stock increased by 84.76% to $1.49. The company's market cap stands at $19.2 million.
  • Spruce Biosciences (NASDAQ:SPRB) stock rose 54.8% to $201.86. The company's market cap stands at $73.4 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) stock increased by 37.41% to $2.13. The company's market cap stands at $2.3 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares rose 29.43% to $1.82. The market value of their outstanding shares is at $19.4 million.
  • Lexeo Therapeutics (NASDAQ:LXEO) stock rose 28.9% to $8.34. The market value of their outstanding shares is at $349.3 million.

Losers

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.